🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite progress in pharmacological and non-pharmacological treatment in re...
Status
Completed
Location
Cantonal Hospital Baselland Liestal
Start Date
2014-01
Trial ID
NCT02386722
Treatments Being Tested
This is a multi-center randomized, sham-controlled clinical trial to determ...
Status
Recruiting
Location
University of Alabama, Lung Health Center
Start Date
2024-05-24
Trial ID
NCT06376994
Treatments Being Tested
Danirixin (DNX) is a selective CXC chemokine receptor (CXCR2) antagonist be...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-04-25
Trial ID
NCT03034967
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, 2-peri...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-23
Trial ID
NCT02275052
Treatments Being Tested
The purpose of this study is to further figure out differences of glycopyrr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01922271
Treatments Being Tested
This study will assess the efficacy, tolerability and safety of NVA237 comp...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01513460
Treatments Being Tested
This is a pilot study to investigate the effect of danirixin hydrobromide 3...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-10-16
Trial ID
NCT03170232
Treatments Being Tested
Neutrophils are thought to play an important role in the pathophysiology of...
Status
Terminated
Location
Multiple Locations
Start Date
2009-10-01
Trial ID
NCT01006616
Treatments Being Tested
The objective of this study is to evaluate fluticasone furoate/vilanterol c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-03-07
Trial ID
NCT03363191
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696